Gene Symbol | AGO2 |
---|---|
Entrez Gene | 27161 |
Alt Symbol | EIF2C2, Q10 |
Species | Human |
Gene Type | protein-coding |
Description | argonaute RISC catalytic component 2 |
Other Description | CTA-204B4.6|PAZ Piwi domain protein|PPD|argonaute 2|argonaute2|eIF-2C 2|eIF2C 2|eukaryotic translation initiation factor 2C, 2|hAgo2|protein argonaute-2|protein slicer |
Swissprots | Q8WV58 Q96ID1 Q8TCZ5 Q9UKV8 |
Accessions | CAK32193 EAW92207 EAW92208 Q9UKV8 AA909234 AF121255 AAF13034 AI468419 AK096164 AK130012 AL050151 AY077717 AAL76093 BC007633 AAH07633 BC018727 AAH18727 BC054491 BC065217 BC125213 AAI25214 BC125214 BC160104 AAI60104 BT007229 AAP35893 HG501752 XM_011516964 XP_011515266 XM_011516965 XP_011515267 XM_011516966 XP_011515268 XM_011516967 XP_011515269 XM_011516968 XP_011515270 NM_001164623 NP_001158095 NM_012154 NP_036286 |
Function | Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to t |
Subcellular Location | Cytoplasm, P-body. Nucleus. Note=Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8. |
eIF2C CRISPR/Cas9 KO Plasmid (h) - sc-400813 from Santa Cruz Biotechnology
|
||||||||
eIF2C HDR Plasmid (h) - sc-400813-HDR from Santa Cruz Biotechnology
|
||||||||
eIF2C Double Nickase Plasmid (h) - sc-400813-NIC from Santa Cruz Biotechnology
|
||||||||
eIF2C Double Nickase Plasmid (h2) - sc-400813-NIC-2 from Santa Cruz Biotechnology
|
||||||||
eIF2C CRISPR Activation Plasmid (h) - sc-400813-ACT from Santa Cruz Biotechnology
|
||||||||
eIF2C CRISPR Activation Plasmid (h2) - sc-400813-ACT-2 from Santa Cruz Biotechnology
|
||||||||
eIF2C Lentiviral Activation Particles (h) - sc-400813-LAC from Santa Cruz Biotechnology
|
||||||||
eIF2C Lentiviral Activation Particles (h2) - sc-400813-LAC-2 from Santa Cruz Biotechnology
|
||||||||
eIF2C2 siRNA (h) - sc-44409 from Santa Cruz Biotechnology
|
||||||||
eIF2C2 shRNA Plasmid (h) - sc-44409-SH from Santa Cruz Biotechnology
|
||||||||
eIF2C2 shRNA (h) Lentiviral Particles - sc-44409-V from Santa Cruz Biotechnology
|
||||||||
Ago2/eIF2C2 RNAi - H00027161-R01V from Novus Biologicals
|
||||||||
Ago2/eIF2C2 RNAi - H00027161-R01 from Novus Biologicals
|
||||||||
MISSION® esiRNA - EHU024931 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN7750 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND7750 from Sigma-Aldrich
|
||||||||
MISSION® 3′UTR Lenti GoClone™ - HUTR07000 from Sigma-Aldrich
|
||||||||
AGO2 siRNA (Human) - CRH9002 from Cohesion Biosciences
|
||||||||
AGO2 - MBS8210733 from MyBioSource
|
||||||||
shRNA set against Human EIF2C2 (NM_012154.3) - SHH284325 from Creative biogene
|
||||||||
Human AGO2 siRNA - orb269504 from Biorbyt
|
||||||||
AGO2 shRNA Plasmid (Human) - CHH9002 from Cohesion Biosciences
|
||||||||
EIF2C2 miRNA 3'UTR clone - MiUTR3H-08300 from Creative biogene
|
||||||||
EIF2C2 miRNA 3'UTR clone - MiUTR3H-08301 from Creative biogene
|